Tech

Everything you need to know about the monkeypox vaccines


Sørensen said Bavarian Nordic contracted to develop a safer smallpox vaccine for the United States in the early 2000s, amid concerns that smallpox could be used as a weapon of terrorism. biology against the country, Sørensen said. The company has been manufacturing and storing Jynneos for the country in the years since.

Sørensen denied there had been any bottlenecks in vaccine delivery so far. He said on July 28 that the company has responded to every request it has received since the start of the outbreak – including requests from every affected country.

“We have not seen any requests beyond our current capacity to date,” says Sørensen. “We’ve heard from many sources that there’s a limitation, but we think it’s actually a ghost.”

Sørensen says the ability to deliver these doses largely depends on luck. “When the outbreak broke out, we did… truly random, the equivalent of 2 million large doses of our vaccine. [in addition to that owned by the US], and it was turned into a jar right away,” he said. “And that’s what we started selling.”

“Right now there’s only “very little” of that dose left, but the company has “scaled up production,” he added.

Are vaccine reserves shared?

Hope. In addition to the large number of vaccines stored by the Bavarian Nordic, the US Strategic National Stockpile, a stockpile of medicines and emergency medical supplies, includes millions of doses of ACAM2000 and thousands of doses of Jynneos.

Many countries are believed to have stockpiles of smallpox vaccine. “I don’t think people really know which countries have stockpiles and how many vaccines, but it’s not just the US,” Heymann said.

WHO has called on countries with vaccines to share doses with those that do not have vaccines. Some scientists have shown that monkeypox vaccine not yet made available to African countries where the virus is circulating.

“I think we all have to be concerned about equitable access to vaccines,” said Heymann. But he emphasized the fact that these vaccines were developed for stockpiling from the ground up. “They are sold to countries for stockpiling in case smallpox will be used as a weapon of bioterrorism,” he said.

Without the incentive to create stockpiles of vaccines, we wouldn’t have Jynneos. “It’s a real Catch-22, isn’t it,” Hermann said. “It is a complex issue. We need [incentives and financial support to make] these vaccines, but at the same time we need them to be shared as widely as possible. “



Source link

kignews

Kig News: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button